Clinical Guidelines

The Oral GLP‑1 Era Has Arrived 

And chromatographers are about to be very busy…

Share

The FDA's recent approval of oral GLP-1 formulations marks a pivotal change in drug formulation and analytical expectations, shifting from solely injectable biologics. The new oral peptides demand more advanced stability, impurity testing, and control over degradation paths. Analytical complexity increases, necessitating enhanced methodologies such as multi-dimensional chromatography and high-resolution mass spectrometry. Companies must adapt to meet rising regulatory scrutiny while ensuring drug efficacy, as ignorance of impurity profiles poses significant business risks.

Original Source(s)

The Oral GLP‑1 Era Has Arrived 

And chromatographers are about to be very busy…

  • by Sean Orlowicz

  • March 12, 2026

  • 6 min

Related Content

SGLT2 Inhibitors Linked to Better Outcomes in Diabetes and Cirrhosis

A nationwide cohort study found lower rates of cardiorenal complications and hepatic decompensation

Mapping the Metabolism of Plant Mixtures 

A multilayer networking workflow reveals mixture-dependent metabolism of kratom alkaloids A multilayer networking workflow reveals mixture-dependent metabolism of kratom alkaloids 

  • March 10, 2026

  • 3 min
Diabetes Risk Assessment: A New Approach

Blood-based epigenetic markers show strong prognostic potential for Type 2 diabetes